|
⚲
|
| Keyboard |
| Imara Inc | |
|---|---|
| Ticker | ELVN |
| CIK # | 0001672619 |
| CUSIP | 29337E102 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 116 Huntington Avenue 6th Floor, Boston, MA 02116 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Enliven Therapeutics Inc | 2024-04-03 | 90.0 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| Imara Inc | 2019-03-29 | 44.1 M | Exemption: 506(b) · Remaining: $18,899,612 · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001672619] | 10-K | |
| [0001672619] | 10-Q | |
| [0001672619] | 3 | |
| [0001672619] | 4 | |
| [0001672619] | 8-K | |
| [0001672619] | D | |
| [0001672619] | SC 13D | |
| [0001672619] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Collins Helen Louise
Common Stock
|
2026-03-25 | Sell | 40,000 | $35.10 | 1,404,000 |
|
Collins Helen Louise
Common Stock
|
2026-03-25 | Option exercise | 40,000 | $2.48 | 99,200 |
|
Collins Helen Louise
Stock Option (right to buy) · derivative
|
2026-03-25 | Option exercise | 40,000 | $0.00 | |
|
Collins Helen Louise
Common Stock
|
2026-03-17 | Option exercise | 5,000 | $2.48 | 12,400 |
|
Collins Helen Louise
Common Stock
|
2026-03-17 | Sell | 5,000 | $27.76 | 138,800 |
|
Collins Helen Louise
Stock Option (right to buy) · derivative
|
2026-03-17 | Option exercise | 5,000 | $0.00 | |
|
Collins Helen Louise
Common Stock
|
2026-03-10 | Sell | 10,129 | $30.19 | 305,795 |
|
Collins Helen Louise
Common Stock
|
2026-03-10 | Option exercise | 10,129 | $2.48 | 25,120 |
|
Collins Helen Louise
Stock Option (right to buy) · derivative
|
2026-03-10 | Option exercise | 10,129 | $0.00 | |
|
Collins Helen Louise
Stock Option (right to buy) · derivative
|
2026-03-09 | Option exercise | 29,871 | $0.00 | |
|
Collins Helen Louise
Common Stock
|
2026-03-09 | Sell | 29,871 | $30.02 | 896,727 |
|
Collins Helen Louise
Common Stock
|
2026-03-09 | Option exercise | 29,871 | $2.48 | 74,080 |
|
Hohl Benjamin
Common Stock
|
2026-03-06 | Sell | 10,000 | $29.58 | 295,800 |
|
Heyman Richard A
Common Stock
|
2026-02-17 | Sell | 1,230 | $26.18 | 32,201 |
|
Collins Helen Louise
Common Stock
|
2026-02-17 | Sell | 45,000 | $26.17 | 1,177,650 |
|
Collins Helen Louise
Stock Option (right to buy) · derivative
|
2026-02-17 | Option exercise | 45,000 | $0.00 | |
|
Collins Helen Louise
Common Stock
|
2026-02-17 | Option exercise | 45,000 | $2.48 | 111,600 |
|
Hohl Benjamin
Common Stock
|
2026-02-12 | Grant | 25,000 | $0.00 | |
|
Patel Anish
Common Stock
|
2026-02-12 | Grant | 20,000 | $0.00 | |
|
Hohl Benjamin
Stock Option (right to buy) · derivative
|
2026-02-12 | Grant | 150,000 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 174 | 64,779,084 |
| 2025-12-31 | 128 | 62,427,299 |
| 2025-09-30 | 135 | 59,483,927 |
| 2025-06-30 | 126 | 58,981,234 |
| 2025-03-31 | 124 | 49,888,035 |
| 2024-12-31 | 116 | 49,626,032 |
| 2024-09-30 | 104 | 47,709,471 |
| 2024-06-30 | 96 | 48,947,300 |
| 2024-03-31 | 75 | 44,600,922 |
| 2023-12-31 | 63 | 39,104,145 |
| 2023-09-30 | 63 | 39,087,578 |
| 2023-06-30 | 64 | 39,126,569 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Assenagon Asset Management SA | [2026-06-30] | SOLE | 306,574 | 306,574 |
| TEMA ETFS LLC | [2026-06-30] | SOLE | 60,694 | 60,694 |
| Handelsbanken Fonder AB | [2026-06-30] | SOLE | 0 | 17,300 |
| PSP Research LLC | [2026-06-30] | SOLE | 0 | 7,000 |
| Versant Capital Management Inc | [2026-06-30] | SOLE | 1,581 | 1,581 |
| Farther Finance Advisors LLC | [2026-06-30] | SOLE | 0 | 784 |
| Gamma Investing LLC | [2026-06-30] | DFND | 228 | 228 |
| MassMutual Private Wealth & Trust FSB | [2026-06-30] | SOLE | 208 | 208 |
| FNY Investment Advisers LLC | [2026-06-30] | DFND | 2,500 | 2 | Prev | Page 1 | Next |